Analysen von Catherine Farrant
| 03.02.16 | Tate Lyle Neutral | JP Morgan Chase & Co. | |
| 10.11.15 | Tate Lyle Neutral | JP Morgan Chase & Co. | |
| 29.10.15 | BAT overweight | JP Morgan Chase & Co. | |
| 02.10.15 | BAT overweight | JP Morgan Chase & Co. | |
| 16.09.15 | BAT overweight | JP Morgan Chase & Co. | |
| 07.08.15 | BAT kaufen | JP Morgan Chase & Co. | |
| 31.07.15 | Tate Lyle Neutral | JP Morgan Chase & Co. | |
| 30.07.15 | BAT overweight | JP Morgan Chase & Co. | |
|
Werbung
|
|||
| 24.06.15 | BAT overweight | JP Morgan Chase & Co. | |
| 24.06.15 | Givaudan overweight | JP Morgan Chase & Co. | |
| 01.06.15 | BAT kaufen | JP Morgan Chase & Co. | |
| 29.05.15 | Tate Lyle Neutral | JP Morgan Chase & Co. | |
| 20.05.15 | Tate Lyle Neutral | JP Morgan Chase & Co. | |
| 13.05.15 | BAT overweight | JP Morgan Chase & Co. | |
| 22.04.15 | Tate Lyle Neutral | JP Morgan Chase & Co. | |
| 07.04.15 | Tate Lyle Neutral | JP Morgan Chase & Co. | |
| 09.02.15 | Tate Lyle Neutral | JP Morgan Chase & Co. | |
| 02.10.14 | Symrise Neutral | JP Morgan Chase & Co. | |
| 02.10.14 | Symrise Neutral | JP Morgan Chase & Co. | |
| 02.10.14 | Tate Lyle Neutral | JP Morgan Chase & Co. | |
| 02.10.14 | Givaudan overweight | JP Morgan Chase & Co. | |
| 24.09.14 | Tate Lyle Neutral | JP Morgan Chase & Co. | |
| 25.07.14 | Tate Lyle overweight | JP Morgan Chase & Co. | |
| 04.04.14 | Tate Lyle overweight | JP Morgan Chase & Co. | |
| 01.04.14 | Givaudan overweight | JP Morgan Chase & Co. | |
| 17.10.12 | Novozymes A-S (B) hold | Deutsche Bank AG | |